219 related articles for article (PubMed ID: 16639693)
1. Prognostic significance of PU.1 in follicular lymphoma.
Torlakovic EE; Bilalovic N; Golouh R; Zidar A; Angel S
J Pathol; 2006 Jul; 209(3):352-9. PubMed ID: 16639693
[TBL] [Abstract][Full Text] [Related]
2. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of inflammatory cytokines at diagnosis correlate to the bcl-6 and CD10 defined germinal centre (GC) phenotype and bcl-2 expression in patients with diffuse large B-cell lymphoma.
Pedersen LM; Jürgensen GW; Johnsen HE
Br J Haematol; 2005 Mar; 128(6):813-9. PubMed ID: 15755285
[TBL] [Abstract][Full Text] [Related]
4. Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma.
Bilalovic N; Blystad AK; Golouh R; Nesland JM; Selak I; Trinh D; Torlakovic E
Am J Clin Pathol; 2004 Jan; 121(1):34-42. PubMed ID: 14750238
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
Muris JJ; Meijer CJ; Vos W; van Krieken JH; Jiwa NM; Ossenkoppele GJ; Oudejans JJ
J Pathol; 2006 Apr; 208(5):714-23. PubMed ID: 16400625
[TBL] [Abstract][Full Text] [Related]
6. High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.
Carreras J; Lopez-Guillermo A; Roncador G; Villamor N; Colomo L; Martinez A; Hamoudi R; Howat WJ; Montserrat E; Campo E
J Clin Oncol; 2009 Mar; 27(9):1470-6. PubMed ID: 19224853
[TBL] [Abstract][Full Text] [Related]
7. Abnormal patterns of antigenic expression in follicular lymphoma: a flow cytometric study.
Ray S; Craig FE; Swerdlow SH
Am J Clin Pathol; 2005 Oct; 124(4):576-83. PubMed ID: 16146823
[TBL] [Abstract][Full Text] [Related]
8. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
Richendollar BG; Pohlman B; Elson P; Hsi ED
Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S
Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
[TBL] [Abstract][Full Text] [Related]
10. Absence of cyclin-D2 and Bcl-2 expression within the germinal centre type of diffuse large B-cell lymphoma identifies a very good prognostic subgroup of patients.
Amen F; Horncastle D; Elderfield K; Banham AH; Bower M; Macdonald D; Kanfer E; Naresh KN
Histopathology; 2007 Jul; 51(1):70-9. PubMed ID: 17593082
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of the antiapoptotic Mcl-1 and Bcl-2 proteins in follicular lymphoma.
Michels J; Foria V; Mead B; Jackson G; Mullee M; Johnson PW; Packham G
Br J Haematol; 2006 Mar; 132(6):743-6. PubMed ID: 16487175
[TBL] [Abstract][Full Text] [Related]
12. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.
Federico M; Bellei M; Marcheselli L; Luminari S; Lopez-Guillermo A; Vitolo U; Pro B; Pileri S; Pulsoni A; Soubeyran P; Cortelazzo S; Martinelli G; Martelli M; Rigacci L; Arcaini L; Di Raimondo F; Merli F; Sabattini E; McLaughlin P; Solal-Céligny P
J Clin Oncol; 2009 Sep; 27(27):4555-62. PubMed ID: 19652063
[TBL] [Abstract][Full Text] [Related]
13. Follicular origin of a subset of CD5+ diffuse large B-cell lymphomas.
Manazza AD; Bonello L; Pagano M; Chiusa L; Novero D; Stacchini A; Martini G; Vitolo U; Tarella C; Inghirami G; Palestro G; Chiarle R
Am J Clin Pathol; 2005 Aug; 124(2):182-90. PubMed ID: 16040287
[TBL] [Abstract][Full Text] [Related]
14. International and Italian prognostic indices in follicular lymphoma.
Perea G; Altés A; Montoto S; López-Guillermo A; Bosch F; Jiménez M; Esteve J; Domingo E; Ribera JM; Pedro C; Martino R; Briones J; Sureda A; Brunet S; Sierra J; Montserrat E
Haematologica; 2003 Jun; 88(6):700-4. PubMed ID: 12801847
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
Vose JM; Bierman PJ; Loberiza FR; Lynch JC; Bociek GR; Weisenburger DD; Armitage JO
Biol Blood Marrow Transplant; 2008 Jan; 14(1):36-42. PubMed ID: 18158959
[TBL] [Abstract][Full Text] [Related]
16. Initial features and outcome of cutaneous and non-cutaneous primary extranodal follicular lymphoma.
Fernández de Larrea C; Martínez-Pozo A; Mercadal S; García A; Gutierrez-García G; Valera A; Ghita G; Colomo L; Gainza E; Villamor N; Nomdedeu B; Estrach T; Montserrat E; Campo E; López-Guillermo A
Br J Haematol; 2011 May; 153(3):334-40. PubMed ID: 21375524
[TBL] [Abstract][Full Text] [Related]
17. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M
Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730
[TBL] [Abstract][Full Text] [Related]
18. Primary lymphoma of bone: extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype.
Heyning FH; Hogendoorn PC; Kramer MH; Holland CT; Dreef E; Jansen PM
J Clin Pathol; 2009 Sep; 62(9):820-4. PubMed ID: 19734480
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of detecting strong bcl-2 protein expression with flow cytometry in follicular lymphoma].
Kobayashi S; Motomura S; Kishi Y; Hashimoto C; Maruta A; Kodama F
Rinsho Ketsueki; 2004 Jul; 45(7):530-8. PubMed ID: 15359912
[TBL] [Abstract][Full Text] [Related]
20. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]